Fecal Microbiota Transplantation (FMT) showing promise beyond C. difficile infection in conditions like IBD, IBS, and metabolic disorders.
Celine Druart, from the Pharmabiotic Research Institute, highlighted critical challenges in the microbiome field, particularly around the standardization of clinical protocols and analytical methods.
High levels of bile acids drive bacterial colonization of the gut and exacerbate gut inflammation by altering the intestinal environment.
The effects of coffee on health may be mediated by gut microbes such as L. asaccharolyticus and their metabolites.
Nigel Titford, CEO at Biogaia Pharma, discusses the strategic considerations and challenges involved in working across both the dietary supplement and pharmaceutical sectors.
Mice born to mothers exposed to Akkermansia muciniphila during pregnancy showed improvements in stem cell activity.
A study revealed a link between gut microbiota composition and brain development in preterm infants, suggesting that specific bacteria and their metabolites can influence neurodevelopment.
Industry
Sponsored by
In July 2024, the journal Frontiers in Microbiology presented a groundbreaking method that overcomes this hurdle: the Flow-FISH method.
Industry
Sponsored by
Probiotic intervention in the gut–prostate axis with novaPROX combo: insights from an in vitro study
The study published on Foods Journal researched the mechanisms of action of Probionova's novaPROX product using a 3D intestinal barrier model and a co-culture prostatic model.
On the second anniversary of its launch, Ferring Pharmaceuticals’ REBYOTA remains a landmark innovation in the prevention of recurrent Clostridioides difficile.
